About 475 million people, or 10 percent of the world's population, suffer from rare diseases, and over 80% of them are genetic in nature.
The average time to diagnosis is seven years - the so-called diagnostic odyssey. This places a considerable burden on patients and their families.
We aim to pave a way forward by improving the accuracy, speed and accessibility of genetic testing, providing patients with the right information at the right time and empowering them to make informed health decisions.
Recent developments in genetic sequencing technologies have revolutionized genomics, and developments expected in the coming years will make it an essential part of medicine.
As genetic testing becomes more widespread in healthcare, the interpretation of the vast information it provides has become the biggest bottleneck in extending it to more patients and healthcare systems.
That’s where our journey started.
We are a proud, diverse, international group of creative problem solvers and humble learners who care about making a positive impact on society and are also aware of the trust placed in us.
For this reason, we value transparency, kindness as well as personal responsibility and encourage your personal growth.
Download our white paper to find out how AION’s white-box approach can help you to improve the quality and throughput of your variant interpretation.
Contact us!
*Nostos Genomics regularly produces webinars, white papers, and other types of content that you may find valuable.
You can unsubscribe at any time. For more information view our Privacy Policy.
